Press release
Recurrent/Metastatic Nasopharyngeal Carcinoma (R/M-NPC) Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2023-2032), Analyzes DelveInsight | Akesobio Inc., Novartis, Viracta Therapeutics, Coherus BioSciences, Chia Tai Tianqing
To Know in detail about the Recurrent/Metastatic Nasopharyngeal Carcinoma market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Recurrent/Metastatic Nasopharyngeal Carcinoma Market Forecast
delveinsight.com/sample-request/nasopharyngeal-carcinoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Recurrent/Metastatic Nasopharyngeal Carcinoma Market Report:
• The Recurrent/Metastatic Nasopharyngeal Carcinoma market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• According to the American Cancer Society, the typical age at diagnosis is around 50 years old, and around 50% of Americans with nasopharyngeal cancer are under the age of 55
• According to Globocan data, 1,898 incident cases of nasopharynx cancer occurred in the United States in 2020, making up a small portion of the estimated 133,354 people affected by the disease worldwide
• The predicted age-standardized incidence rate of nasopharyngeal cancer among males in 2018 was determined to be 0.84-1.6 per 100,000 for the United States and Japan, according to a study titled "The Evolving Epidemiology of Nasopharyngeal Carcinoma" conducted by Chang et al. (2021)
• Key Recurrent/Metastatic Nasopharyngeal Carcinoma Companies: Akesobio Inc., Novartis, Viracta Therapeutics, Coherus BioSciences, Chia Tai Tianqing Pharma, Jiangsu HengRui Medicine, BeiGene, Sichuan Kelun Pharma, Shanghai Miracogen Inc., Akeso, and others
• Key Recurrent/Metastatic Nasopharyngeal Carcinoma Therapies: Penpulimab, DKY709, Nanatinostat, Toripalimab, TQB2858, Famitinib, Tislelizumab, KL-A167, MRG003, Spartalizumab, SHR-1210, Penpulimab, and others
• The Recurrent/Metastatic Nasopharyngeal Carcinoma epidemiology based on gender analyzed that as per the findings from secondary domain, males are most commonly affected in the case of R/M-NPC
• The Recurrent/Metastatic Nasopharyngeal Carcinoma market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Recurrent/Metastatic Nasopharyngeal Carcinoma pipeline products will significantly revolutionize the Recurrent/Metastatic Nasopharyngeal Carcinoma market dynamics.
Recurrent/Metastatic Nasopharyngeal Carcinoma Overview
Nasopharyngeal carcinoma (NPC) accounts for the majority of nasopharyngeal cancers. Three basic categories of NPC exist. Each kind begins with epithelial cells that line the nasopharynx, but under a microscope, the cells of each type have different appearances. There are three types: keratinizing squamous cell carcinoma, non-keratinizing differentiated carcinoma, and non-keratinizing undifferentiated carcinoma.
Get a Free sample for the Recurrent/Metastatic Nasopharyngeal Carcinoma Market Report
https://www.delveinsight.com/report-store/nasopharyngeal-carcinoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Recurrent/Metastatic Nasopharyngeal Carcinoma Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Recurrent/Metastatic Nasopharyngeal Carcinoma Epidemiology Segmentation:
The Recurrent/Metastatic Nasopharyngeal Carcinoma market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Recurrent/Metastatic Nasopharyngeal Carcinoma
• Prevalent Cases of Recurrent/Metastatic Nasopharyngeal Carcinoma by severity
• Gender-specific Prevalence of Recurrent/Metastatic Nasopharyngeal Carcinoma
• Diagnosed Cases of Episodic and Chronic Recurrent/Metastatic Nasopharyngeal Carcinoma
Download the report to understand which factors are driving Recurrent/Metastatic Nasopharyngeal Carcinoma epidemiology trends @ Recurrent/Metastatic Nasopharyngeal Carcinoma Epidemiology Forecast
https://www.delveinsight.com/sample-request/nasopharyngeal-carcinoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Recurrent/Metastatic Nasopharyngeal Carcinoma Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Recurrent/Metastatic Nasopharyngeal Carcinoma market or expected to get launched during the study period. The analysis covers Recurrent/Metastatic Nasopharyngeal Carcinoma market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Recurrent/Metastatic Nasopharyngeal Carcinoma Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Recurrent/Metastatic Nasopharyngeal Carcinoma Therapies and Key Companies
• Penpulimab: Akesobio Inc.
• DKY709: Novartis Pharmaceuticals
• Nanatinostat: Viracta Therapeutics
• Toripalimab: Coherus BioSciences
• TQB2858: Chia Tai Tianqing Pharma
• Famitinib: Jiangsu HengRui Medicine
• Tislelizumab: BeiGene
• KL-A167: Sichuan Kelun Pharma
• MRG003: Shanghai Miracogen Inc.
• Spartalizumab: Novartis
• SHR-1210: Jiangsu HengRui Medicine
• Penpulimab: Akeso
Discover more about therapies set to grab major Recurrent/Metastatic Nasopharyngeal Carcinoma market share @ Recurrent/Metastatic Nasopharyngeal Carcinoma Treatment Market
https://www.delveinsight.com/sample-request/nasopharyngeal-carcinoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Scope of the Recurrent/Metastatic Nasopharyngeal Carcinoma Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Recurrent/Metastatic Nasopharyngeal Carcinoma Companies: Akesobio Inc., Novartis, Viracta Therapeutics, Coherus BioSciences, Chia Tai Tianqing Pharma, Jiangsu HengRui Medicine, BeiGene, Sichuan Kelun Pharma, Shanghai Miracogen Inc., Akeso, and others
• Key Recurrent/Metastatic Nasopharyngeal Carcinoma Therapies: Penpulimab, DKY709, Nanatinostat, Toripalimab, TQB2858, Famitinib, Tislelizumab, KL-A167, MRG003, Spartalizumab, SHR-1210, Penpulimab, and others
• Recurrent/Metastatic Nasopharyngeal Carcinoma Therapeutic Assessment: Recurrent/Metastatic Nasopharyngeal Carcinoma current marketed and Recurrent/Metastatic Nasopharyngeal Carcinoma emerging therapies
• Recurrent/Metastatic Nasopharyngeal Carcinoma Market Dynamics: Recurrent/Metastatic Nasopharyngeal Carcinoma market drivers and Recurrent/Metastatic Nasopharyngeal Carcinoma market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Recurrent/Metastatic Nasopharyngeal Carcinoma Unmet Needs, KOL's views, Analyst's views, Recurrent/Metastatic Nasopharyngeal Carcinoma Market Access and Reimbursement
To know more about Recurrent/Metastatic Nasopharyngeal Carcinoma companies working in the treatment market, visit @ Recurrent/Metastatic Nasopharyngeal Carcinoma Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/nasopharyngeal-carcinoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1. Recurrent/Metastatic Nasopharyngeal Carcinoma Market Report Introduction
2. Executive Summary for Recurrent/Metastatic Nasopharyngeal Carcinoma
3. SWOT analysis of Recurrent/Metastatic Nasopharyngeal Carcinoma
4. Recurrent/Metastatic Nasopharyngeal Carcinoma Patient Share (%) Overview at a Glance
5. Recurrent/Metastatic Nasopharyngeal Carcinoma Market Overview at a Glance
6. Recurrent/Metastatic Nasopharyngeal Carcinoma Disease Background and Overview
7. Recurrent/Metastatic Nasopharyngeal Carcinoma Epidemiology and Patient Population
8. Country-Specific Patient Population of Recurrent/Metastatic Nasopharyngeal Carcinoma
9. Recurrent/Metastatic Nasopharyngeal Carcinoma Current Treatment and Medical Practices
10. Recurrent/Metastatic Nasopharyngeal Carcinoma Unmet Needs
11. Recurrent/Metastatic Nasopharyngeal Carcinoma Emerging Therapies
12. Recurrent/Metastatic Nasopharyngeal Carcinoma Market Outlook
13. Country-Wise Recurrent/Metastatic Nasopharyngeal Carcinoma Market Analysis (2019-2032)
14. Recurrent/Metastatic Nasopharyngeal Carcinoma Market Access and Reimbursement of Therapies
15. Recurrent/Metastatic Nasopharyngeal Carcinoma Market Drivers
16. Recurrent/Metastatic Nasopharyngeal Carcinoma Market Barriers
17. Recurrent/Metastatic Nasopharyngeal Carcinoma Appendix
18. Recurrent/Metastatic Nasopharyngeal Carcinoma Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Related Reports:
Recurrent/Metastatic Nasopharyngeal Carcinoma Pipeline
https://www.delveinsight.com/report-store/recurrent-or-metastatic-nasopharyngeal-carcinoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"Recurrent/Metastatic Nasopharyngeal Carcinoma Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Recurrent/Metastatic Nasopharyngeal Carcinoma market. A detailed picture of the Recurrent/Metastatic Nasopharyngeal Carcinoma pipeline landscape is provided, which includes the disease overview and Recurrent/Metastatic Nasopharyngeal Carcinoma treatment guidelines.
Recurrent/Metastatic Nasopharyngeal Carcinoma Epidemiology https://www.delveinsight.com/report-store/recurrent-or-metastatic-nasopharyngeal-carcinoma-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Recurrent/Metastatic Nasopharyngeal Carcinoma Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Recurrent/Metastatic Nasopharyngeal Carcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports by DelveInsight
Chemotherapy Drugs Market https://www.delveinsight.com/report-store/chemotherapy-drugs-market
Chemotherapy Drugs Market By Drug Class (Alkylating Agents, Mitotic Inhibitors, Antimetabolites, Topoisomerase Inhibitors, And Others), By Indication (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, And Others), By Route Of Administration (Oral And Parenteral), by geography is estimated to register growth at a remarkable CAGR forecast during 2023-2028 owing to increasing prevalence of different cancer types and increasing pharmaceutical trials for chemotherapy drugs.
Connected Drug Delivery Devices Market
https://www.delveinsight.com/report-store/connected-drug-delivery-devices-market
Connected Drug Delivery Devices Market By Product (Connected Sensors [Connected Inhaler Sensors And Connectable Injection Sensors] And Integrated Connected Devices [Connected Inhaler Devices And Connected Injection Devices], By Technology (Bluetooth, Near-Field Communication (NFC), And Others), By End-User (Healthcare Providers And Homecare), And by geography is expected to grow at a steady CAGR forecast till 2028 owing to the increasing prevalence of chronic diseases such as diabetes and improving healthcare it infrastructure across the globe.
Gynecological Devices Market https://www.delveinsight.com/report-store/gynecological-devices-market
Gynecological Devices Market By Product (Gynecological Endoscopy Devices [Hysteroscope, Resectoscope, And Others), Endometrial Ablation Devices [Balloon Ablation Devices, Radiofrequency Ablation Devices, And Others], Contraceptive Devices [Temporary Birth Control And Permanent Birth Control], Diagnostic Imaging Systems, Fluid Management Systems, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Diagnostic Centers, And Others), and by geography is expected to grow at a steady CAGR forecast till 2028 owing to the increasing prevalence of various gynecological ailments and increasing figure of surgical procedures across the globe.
Baby Wipes Market
https://www.delveinsight.com/report-store/baby-wipes-market
Baby Wipes Market By (Wet Wipes And Dry Wipes), By Distribution Channels (Supermarkets And Hypermarkets, E-Commerce, And Others), by geography is estimated to register growth at a remarkable CAGR forecast during 2023-2028 owing to increased adoption of baby wipes for maintaining infant sanitation and increasing product development activities.
Probiotics Market
https://www.delveinsight.com/report-store/probiotics-market
Probiotics Market By Ingredient Type (Bacteria And Yeast), By Product Type (Functional Food And Beverages, Dietary Supplements, And Animal Feed), By Application (Human Nutrition And Animal Nutrition), By Distribution Channels (Supermarkets And Hypermarkets, Convenience Stores, And Others), by geography is estimated to register growth at a remarkable CAGR forecast during 2022-2027 owing to rising demand for probiotics as a preventive healthcare and increasing product development activities.
Artificial Tears Market
https://www.delveinsight.com/report-store/artificial-tears-market
Artificial Tears Market By Product (Cellulose-Derived Tears, Glycerin-Derived Tears, Polyethylene Glycol And Propylene Glycol-Based Tears, And Others), By Delivery Method (Eye Drops And Eye Ointments), By Application (Dry Eye Disease, Allergies And Infections, And Others), and by geography is expected to grow at a steady CAGR forecast till 2028 owing to the increasing prevalence dry eyes syndrome and increasing availability of over the counter (otc) artificial tears.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Recurrent/Metastatic Nasopharyngeal Carcinoma (R/M-NPC) Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2023-2032), Analyzes DelveInsight | Akesobio Inc., Novartis, Viracta Therapeutics, Coherus BioSciences, Chia Tai Tianqing here
News-ID: 3258790 • Views: …
More Releases from DelveInsight Business Research
Cervical Cancer Market size in 7MM was USD ~900 million in 2023 and expected to …
Cervical Cancer companies are ADC therapeutics, Roche, AstraZeneca, Precigen, Puma Biotechnology, Iovance Bio therapeutics, Nykode Therapeutics, ISA Pharmaceuticals, Regeneron, Transgene, Daiichi Sankyo, Merck Sharp & Dohme, Genmab/Pfizer, Advenchen Laboratories, ImmunityBio, Calithera Biosciences, Seagen, Akeso, Verastem, Iovance Biotherapeutics, Xencor and Many Others.
(Albany, USA) DelveInsight's "Cervical Cancer Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Cervical Cancer, historical and forecasted epidemiology as well as the Cervical Cancer market…
Bronchial Spasm Market Forecast 2032: FDA, EMA, PDMA Approvals, Epidemiology, Th …
The Bronchial Spasm Market is primarily driven by the increasing prevalence of respiratory disorders worldwide. Conditions like asthma and chronic obstructive pulmonary disease (COPD) continue to rise, necessitating effective treatments for bronchial spasms, a common symptom in these conditions. Advancements in diagnostic techniques enable early detection, further fueling market growth. Additionally, continuous research and development efforts lead to the introduction of innovative medications and inhaler technologies, enhancing treatment efficacy and…
Biliary Tract Cancer Market Forecast 2034: FDA, EMA, PDMA Approvals, Epidemiolog …
Biliary Tract Cancer companies are Incyte Corporation, Loxo Oncology, Bayer, Roche, Genentech, QED Therapeutics, Agios Pharmaceuticals, Servier Pharmaceuticals, Merck Sharp & Dohme, AstraZeneca, Taiho Oncology, Delcath Systems, Eisai, TransThera Sciences (Nanjing), Basilea Pharmaceutica, Zymeworks, BeiGene, and others.
(Albany, USA) DelveInsight's "Biliary Tract Cancer Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Biliary Tract Cancer, historical and forecasted epidemiology as well as the Biliary Tract Cancer market trends…
Lassa Fever Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FD …
The Lassa Fever market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Lassa Fever pipeline products will significantly revolutionize the Lassa Fever market dynamics.
DelveInsight's "Lassa Fever Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Lassa Fever, historical and forecasted epidemiology as well as the Lassa Fever market trends in the United…
More Releases for Nasopharyngeal
Nasopharyngeal Swab Market: Maintaining a Strong Outlook - Here’s Why
The Ample Market Research (AMR) has announced the addition of the a new industry research that focuses on Nasopharyngeal Swab market and delivers in-depth market analysis and future outlook of Nasopharyngeal Swab market. The study covers significant data which makes the research report a handy resource for managers, analysts, industry experts and other key people get ready-to-access and self-analyzed study along with graphs and tables to help understand market trends,…
Nasopharyngeal Carcinoma Treatment Market Size, Share, Outlook 2026
Nasopharyngeal carcinoma is a rare cancer, affecting the part of throat connecting nose and mouth, known as pharynx. Nasopharyngeal carcinoma are of three types, based on cell appearance under microscope. These include keratinizing squamous cell carcinoma, non- keratinizing differentiated carcinoma, and undifferentiated carcinoma. The early stage symptoms of nasopharyngeal carcinoma are bleeding nose, blockage and stuffiness in nose, persistent ear infection, hearing difficulties, and sore throat whereas, late stage symptoms…
Nasopharyngeal Cancer Market Display Significant Growth by 2022
Nasopharyngeal is a type of cancer which takes place in head or neck. It happens in nasopharynx, which is a upper part of the of the throat behind the nose. It is also called nasopharyngeal carcinoma (NPC). It has also been linked with Epstein-Barr virus.
In 2015, American Society of Clinical Oncology (ASCO) estimated 3200 to be diagnosed with NPC in U.S. The prevalence rate is fairly rate, as one in…
Nasopharyngeal Cancer - Pipeline by GlaxoSmithKline Plc, H1 2018
WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report “Nasopharyngeal Cancer - Pipeline Review, H1 2018”
Nasopharyngeal Cancer
Overview
Nasopharyngeal cancer is a rare type of head and neck cancer. It starts in the upper part of throat, behind the nose. This area is called the nasopharynx. The risk factors of nasopharyngeal cancer may include Epstein-Barr virus.
Symptoms of nasopharyngeal cancer may include blurry or double…
Nasopharyngeal Cancer - Pipeline Review, H2 2017
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nasopharyngeal Cancer - Pipeline Review, H2 2017, provides an overview of the Nasopharyngeal Cancer (Oncology) pipeline landscape.
Nasopharyngeal cancer is a rare type of head and neck cancer. It starts in the upper part of your throat, behind the nose. This area is called the nasopharynx. The risk factors of nasopharyngeal cancer may include Epstein-Barr virus. Symptoms of nasopharyngeal cancer may…
Nasopharyngeal Cancer Pipeline Insight Report 2017- Market Research Hub
Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Nasopharyngeal Cancer - Pipeline Insights - 2017” report provides comprehensive insights of the ongoing therapeutic research and development across Nasopharyngeal Cancer. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Nasopharyngeal Cancer by development stage, therapy…
